Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 2000 Mar 28;97(7):3520–3525. doi: 10.1073/pnas.97.7.3520

The high copper tolerance of Candida albicans is mediated by a P-type ATPase

Ziva Weissman *, Israela Berdicevsky *, Ben-Zion Cavari , Daniel Kornitzer *,
PMCID: PMC16272  PMID: 10737803

Abstract

The pathogenic yeast Candida albicans has higher resistance than the baker's yeast Saccharomyces cerevisiae to elevated concentrations of copper. To understand the basis of this differential resistance, we performed a functional screen for C. albicans genes involved in copper detoxification. Here, we report the isolation of two such genes: a metallothionein, CaCUP1, and a copper-transporting P-type ATPase, CaCRP1. Both genes are induced by extracellular copper. Gene disruptions indicated that the copper extrusion pump is responsible for the unusual resistance of C. albicans to copper, whereas the metallothionein is responsible for the residual copper resistance of the Cacrp1Δ mutant. We show further that under acidic and anaerobic conditions, such as prevail in the natural niche of C. albicans, the digestive tract of animals, CaCRP1 function becomes essential for survival in the presence of even very low copper concentrations. These observations suggest that copper in the gastrointestinal tract may present a toxic challenge to which enteric organisms had to adapt.

Keywords: copper toxicity, metallothionein


Copper, a cofactor of many cellular enzymes, is an essential element. To cope with low-copper environments, yeast (Saccharomyces cerevisiae) cells possess a high-affinity copper import system consisting of two copper transporters, Ctr1 and Ctr3 (1, 2). It is likely that the substrate for copper transport is reduced copper, Cu(I). Thus, in aerobic environments, the pathway of copper import also includes plasma membrane-associated cupric reductases that reduce Cu(II) to Cu(I) (3, 4).

Although copper is essential, high copper concentrations are toxic, in large measure because copper catalyzes the synthesis of reactive oxygen species (5). Importantly, however, copper is also toxic under anaerobic conditions, both in bacteria (6, 7) and in yeast (8). Resistance to high copper concentrations is achieved by a variety of mechanisms. In some prokaryotes, copper resistance is mediated by extrusion pumps of the P-type ATPase family of transporters (911). In eukaryotes, two major mechanisms of resistance to elevated extracellular copper are shutdown of copper uptake and synthesis of metallothioneins, which function as copper chelators. In S. cerevisiae, exposure to high copper concentrations results in down-regulation of the copper transporter genes CTR1 and CTR3 and of the cupric reductase FRE1 (4, 12, 13) as well as in destabilization of the Ctr1 protein (14). Inability to down-regulate these genes results in hypersensitivity to copper (15). High copper concentrations also lead to the induction of small proteins, metallothioneins (16), which tightly bind copper via the thiol groups of cysteine residues arranged in a typical C-X-C sequence. The critical role in copper resistance of the main copper-induced metallothionein in yeast, CUP1, is attested by the fact that cup1Δ mutants are highly sensitive to copper (17).

Copper-transporting P-type ATPases are found in eukaryotes as well, where they play a major role in intracellular copper transport. Eukaryotic copper-transporting P-type ATPases include the yeast Ccc2 protein (18) and the human Wilson and Menkes disease proteins (1922). Yeast Ccc2 was genetically shown to be required for growth in low iron concentrations. Its function is to transport copper into a post-Golgi compartment, to allow biogenesis of the multicopper ferric oxidase Fet3. Fet3, in turn, is required for iron uptake (23). The Menkes and Wilson disease proteins are similarly involved in transport of copper to a post-Golgi compartment in mammalian cells. Expression of these proteins in yeast complements the iron import deficiency of the ccc2Δ mutant (2426). In addition, in cultured animal cells exposed to elevated copper concentrations, these proteins are able to migrate to the plasma membrane or to a cytoplasmic vesicular compartment (25, 2729); in this way, they may increase the resistance of the cell to copper.

Commensal and pathogenic organisms have by necessity adapted to growth—or at least survival—in the specific environments of the animal body. Many parameters of these environments are still unknown. Candida albicans is a commensal organism, found in the mouth and gastrointestinal tract of 30–50% of the population. It is also a major fungal opportunistic pathogen, often causing mucosal, cutaneous, or nail infections. Deep-seated life-threatening infection is less common and occurs primarily in immunocompromised or debilitated patients (30). The yeast S. cerevisiae, in contrast, is isolated only rarely from patients. One approach to gain better understanding of the survival capacity of pathogenic microorganisms in the animal body would be to study the molecular basis underlying the differential resistance to environmental insults of a pathogenic vs. a nonpathogenic microorganism—for example, C. albicans and S. cerevisiae. Here, we report that C. albicans is unusually resistant to copper, and we identify the molecular basis of this resistance.

Materials and Methods

Plasmid Constructions.

Plasmids KB806 (CaCRP1) and KB807 (CaCUP1) are clones from a C. albicans genomic DNA library constructed into a 2-μ URA3 yeast vector (31). The whole KB807 insert (2,538 bp) and 5,023 bp of the 6,094-bp KB806 insert were sequenced on both strands. The KB806 insert was recloned into pRS315 (32) to yield KB815. KB537 (our plasmid collection) carries the yeast EF1A coding region under the GAL1, 10 promoter. Plasmids KB787 and KB788 were used for deleting CaCRP1 and CaCUP1 from the C. albicans genome, respectively. Both contain the CaURA3 gene between two direct hisG repeats (33), flanked by the 5′ and 3′ regions of CaCRP1 and CaCUP1, respectively, in the pBSIIKS+ vector (Stratagene). KB787 contains a 5′ fragment extending from the beginning of the KB806 insert sequence (−2120 relative to the CaCRP1 initiation site) to a NotI site introduced by PCR at position + 1 and a 3′ fragment extending from a HindIII site at position + 3034 to the end of the KB806 insert (= 942 bp). KB788 contains a 5′ fragment extending from the beginning of the insert of KB807 (−1,324 relative to the CaCUP1 initiation site) to a BamHI site introduced by PCR at + 1 and a 3′ fragment extending from an NdeI site immediately downstream of CaCUP1 to the end of the KB806 insert (= 1,086 bp). KB969 contains a CaCRP1-GFP fusion constructed by PCR by using a yeast codon-modified GFP (34).

Yeast Strain Constructions.

All yeast transformations were performed by the standard lithium acetate method (35). Strain DTY 113 (α ura3–50 leu2–3,112 trp1–1 gal1 his cup1Δ61) (36) was kindly provided by Dennis Thiele (University of Michigan, Ann Arbor, MI). The ccc2ΔURA3 mutant (YRS7) (23) and its isogenic wild type (YPH252) were kindly provided by Bob Stearman (National Cancer Institute). The C. albicans wild-type strains used were CBS562 (Centraal Bureau voor Schimmelcultures, Delft, The Netherlands) and CAF3–1 (33). Deletions were achieved by transforming the CAF3–1 strain with 5 μg of either KB787 or KB788 digested with SacI and KpnI. Transformants representing the desired homologous recombination were identified by Southern blotting. To sequentially delete both alleles of a single gene or multiple genes rare URA revertants of the URA+ transformants that have deleted the URA3 marker via homologous recombination between the hisG repeats were selected on 5-fluoroorotic acid (37). To ascertain that the phenotypes are entirely attributable to the site-directed deletions rather than to secondary genetic changes, each strain was constructed independently at least twice from the starting wild-type strain. KC13 is the double CaCUP1 deletant, KC16 is the double CaCRP1 deletant, and KC24 is KC13 deleted for both alleles of CaCRP1.

Media; Phenotypic Tests.

Yeast extract/peptone/dextrose and synthetic complete media were as described (35), except that the amino acids were added to 0.1 mg/ml each and for C. albicans, uridine was used rather than uracil. Sensitivity to copper was tested on plates as indicated or in liquid culture by using synthetic medium supplemented with the indicated amounts of CuSO4. For sensitivity tests in acidic anaerobic conditions, the media were titrated to pH 3 with HCl and supplemented with 10 μg/ml ergosterol/0.5 mg/ml oleic acid (Tween 80). Cu+ was added as CuCl from a 1 M stock in concentrated HCl. Transcript levels were measured by Northern blotting, followed by hybridization with radioactive probes and quantitation with a phosphorimager. For each sample, the data were normalized to the level of EF1α mRNA by reprobing the membranes with an EF1A probe derived from plasmid KB537 (the high homology of the EF1A gene between S. cerevisiae and C. albicans, 90%, allowed us to use the S. cerevisiae probe for C. albicans). For intracellular copper monitoring, cells grown as indicated were washed four times with ice-cold 50 mM Tris/20 mM EDTA, pH 7.5, and the copper concentration was measured with a Varian SpectraA 250 atomic absorption spectrophotometer equipped with a graphite furnace.

Results

Isolation of C. albicans Genes Conferring Copper Resistance in S. cerevisiae.

The baker's yeast, S. cerevisiae, is relatively resistant to copper and is able to grow in up to 2 mM CuSO4 in synthetic medium. We found, however, that C. albicans is even more copper resistant and grows in up to 20 mM CuSO4 in synthetic medium (see Fig. 1A for a comparison of the growth of both yeasts in the presence of an elevated concentration of copper and Fig. 6B, below, for a growth inhibition curve). In rich (yeast extract/peptone/dextrose) medium, C. albicans is able to grow even in up to 50 mM CuSO4 (results not shown). To identify the genetic factor determining the high copper tolerance of C. albicans, we performed a screen to isolate C. albicans genes able to confer increased copper resistance to a highly copper-sensitive S. cerevisiae metallothionein mutant. A C. albicans genomic library carried on a yeast 2 μ (high-copy) vector (31) was transformed into strain DTY113 (cup1Δ), which is normally unable to grow even on 10 μM CuSO4, and the cells were plated on 50 μM CuSO4. Eight independent plasmid clones that conferred to the cup1Δ strain the ability to grow on 50 μM CuSO4 were isolated: seven contained overlapping fragments, and one was unique. A representative of the first group and the unique clone were sequenced. Sequence analysis revealed, respectively, an ORF with metallothionein homology, which we called CaCUP1, and an ORF with homology to copper-transporting P-type ATPases, which we called CaCRP1 (for copper resistance-associated P-type ATPase; see below). Complementation of the copper sensitivity of the cup1Δ mutant by these two genes is shown in Fig. 1B.

Figure 1.

Figure 1

(A) Differential copper resistance of C. albicans and S. cerevisiae. C. albicans strain CAF3–1 and S. cerevisiae strain W303 were grown 2 days at 30° on yeast extract/peptone/dextrose supplemented with 12 mM CuSO4. (B) Functional complementation of the S. cerevisiae cup1Δ copper sensitivity by two C. albicans genes. S. cerevisiae strain DTY113 (cup1Δ) carrying the vector plasmid or plasmid KB807 or plasmid KB806 was grown for 3 days on synthetic complete − URA medium supplemented with 50 μM CuSO4.

Figure 6.

Figure 6

(A) Comparison of growth inhibition by CuSO4 in C. albicans strains crp1Δ (KC16), crp1Δ cup1Δ (KC24), and S. cerevisiae cup1Δ (DTY113). (B) CaCRP1 increases the resistance of wild-type S. cerevisiae (W303) to copper. The assays were performed as described in the legend to Fig. 4.

The CaCUP1 ORF is short, 33 codons, and contains three groups of C-X-C sequences, characteristic of copper metallothioneins (Fig. 2 Upper). The CaCRP1 ORF is 1,197 codons long and contains all of the signature domains of copper-transporting ATPases (Fig. 2 Lower). The highest homology was found with the catalytic domain of the P-type ATPases. Also conserved are the GMXCXXC sequences, found in the amino-terminal domain of this type of proteins (3840). These sequences are thought to bind free copper or chaperone-bound copper and transfer it to the transmembrane channel domain of the protein. CaCRP1contains three such consensus sequences and, in addition, two CXXC motifs closer to the amino terminus (Fig. 2).

Figure 2.

Figure 2

Sequences of the C. albicans proteins CaCup1 and CaCrp1. (Upper) CaCup1 protein sequence derived from the DNA sequence. (Lower) Schematic depiction of the sequence features of CaCrp1. Eight putative transmembrane segments, centered around positions 460, 505, 550, 590, 740, 785, 1130, and 1165, were predicted on the basis of Kyte–Doolittle hydropathy analysis (41). The five predicted metal-binding motifs start at coordinates 12, 135, 178, 262, and 346. Three highly conserved P-type ATPase motifs within the catalytic domain are also indicated: CPC (position 784), DKTGT (position 829), and GDGIND (position 1060).

Transcriptional Induction of CaCRP1 and CaCUP1 by Copper.

We expected that if CaCUP1 and CaCRP1 are involved in copper resistance in C. albicans, these two genes should be induced by the addition of copper to the medium. This is indeed the case: Northern blot analysis revealed that the addition of 2 mM CuSO4 to an exponentially growing C. albicans culture leads to rapid but transient induction of both genes (Fig. 3), similar to the induction of S. cerevisiae CUP1 (42).

Figure 3.

Figure 3

Induction of CaCUP1 and CaCRP1 by copper. CuSO4 (2 mM) was added to a logarithmic culture of wild-type C. albicans cells (CBS562). RNA was extracted at the indicated times after copper addition, and the mRNAs for CaCUP1 and CaCRP1 were detected by Northern blotting with specific probes and quantitated with a phosphorimager. EF1α mRNA was used as an internal control to which the data of each sample were normalized. The basal mRNA level was set at 1.

Phenotypic Analysis of Deletions of CaCRP1 and CaCUP1.

To address directly the role of CaCUP1 and CaCRP1 in copper tolerance, we deleted these genes from the C. albicans genome by homologous recombination (see Materials and Methods). The Cacup1Δ/Cacup1Δ strain displayed only a slightly increased susceptibility to copper, with a reduction of the minimal inhibitory concentration (MIC) of CuSO4 from 20 mM to 10 mM in synthetic medium. In contrast, disruption of CaCRP1 had a dramatic effect on copper sensitivity: the MIC of CuSO4 of the Cacrp1Δ/Cacrp1Δ strain was reduced to 0.5 mM (Fig. 4). The heterozygotes showed no growth phenotypes on copper. We also tested whether CaCrp1 may be involved in resistance to other heavy metals; however, the Cacrp1Δ/Cacrp1Δ strain was equally resistant to Zn2+, Cd2+, and Ag+ as the wild-type strain (results not shown).

Figure 4.

Figure 4

Growth inhibition by CuSO4 of C. albicans strains deleted for both alleles of CaCRP1 (KC13) or CaCUP1 (KC16). Cultures were grown overnight while shaking in synthetic complete medium supplemented with the indicated concentrations of CuSO4. The optical density of the cultures at 600 nm was measured at the end of the incubation.

It is likely that the rapid induction of both CaCRP1 and CaCUP1 by extracellular copper (Fig. 3) reflects the existence of a transcription factor that responds to the presence of copper in the cytoplasm, by analogy with S. cerevisiae Ace1 or Candida glabrata Amt1 (4345). The levels of CaCRP1 and CaCUP1 mRNA could thus serve as a measure of intracellular copper. On the basis of this reasoning, we measured the transcript levels of each of these two genes when the other one is deleted (Fig. 5). In the Cacrp1Δ/Cacrp1Δ mutant, CaCUP1 mRNA levels are elevated 7-fold, whereas in the Cacup1Δ/Cacup1Δ strain, CaCRP1 mRNA levels were elevated 6-fold. Thus, both genes appear important for maintaining intracellular copper homeostasis, even when extracellular copper levels are low.

Figure 5.

Figure 5

Enhanced basal expression of CaCUP1 and CaCRP1 in Cacrp1Δ and Cacup1Δ mutants, respectively. mRNA levels in logarithmic cultures of the two mutants and the wild-type strain were measured as described in the legend to Fig. 3. The basal level in the wild type was set at 1.

The MIC of 0.5 mM seen in the Cacrp1Δ/Cacrp1Δ strain is still well above that of the S. cerevisiae cup1Δ mutant and close to that of the wild-type S. cerevisiae (2 mM; see Fig. 6B). We asked whether CaCUP1 was responsible for this residual copper resistance by constructing a strain deleted for both genes. The Cacrp1Δ/Cacrp1Δ Cacup1Δ/Cacup1Δ strain was extremely copper sensitive and failed to grow even in 25 μM of CuSO4, close to what is observed for the S. cerevisiae cup1Δ mutant (Fig. 6A). Thus, the two genes we identified encode the two main copper detoxification factors of C. albicans. However, the phenotypes of the individual mutants suggest that CaCRP1 has a more prominent role in copper detoxification than CaCUP1, and that it is responsible for the relatively higher copper resistance of C. albicans vs. S. cerevisiae. To test this further, we transformed a plasmid carrying CaCRP1 into a wild-type S. cerevisiae strain and measured its resistance to copper. As shown in Fig. 6B, the MIC of CuSO4 for the S. cerevisiae strain carrying CaCRP1 was significantly increased, from 2 mM to 5 mM.

If indeed the function of CaCrp1 is to extrude copper from the cells, then copper would be predicted to accumulate in the mutant cells. We monitored copper accumulation in C. albicans wild type vs. the crp1 double deletion mutant by atomic absorption spectrophotometry. As shown in Fig. 7, the mutant cells grown in normal yeast nitrogen base minimal medium (containing about 0.4 μM CuSO4) already accumulated over four times more copper; after growth overnight in 0.5 mM CuSO4, 40 times more copper had accumulated in the mutant cells.

Figure 7.

Figure 7

Copper accumulation in wild-type vs. Cacrp1Δ mutant cells. (Left) Cells grown overnight in medium without added copper. (Right) Cell grown overnight in the presence of 0.5 mM CuSO4.

CaCrp1 Localization.

The S. cerevisiae copper transporter Ccc2 is located in the trans-Golgi network, where it transfers copper from the cytosol to the lumen (46). Biogenesis of the multicopper ferric oxidase Fet3, which occurs in the trans-Golgi compartment, requires Ccc2. Because Fet3 is required for high-affinity iron transport, the ccc2Δ mutant is unable to grow in low iron or in medium containing the iron chelator ferrozine (23). We found that CaCRP1 is unable to complement the growth defect of the S. cerevisiae ccc2Δ strain on ferrozine (data not shown), suggesting that it does not function in the trans-Golgi compartment. The function of CaCrp1 in copper efflux from the cell suggests that it is located in the plasma membrane. This prediction was tested with a CaCrp1–green fluorescent protein (GFP) fusion. The CaCrp1–GFP fusion is able to complement the copper sensitivity of a S. cerevisiae cup1Δ mutant, indicating that it is functional (data not shown). Fluorescence microscopy shows that the fusion protein is indeed primarily located in the plasma membrane (Fig. 8). Additional perinuclear staining in many cells, indicative of endoplasmic reticulum localization, may represent molecules in transit to the plasma membrane.

Figure 8.

Figure 8

Localization of a Crp1-GFP fusion protein. KY676 cells (diploid cup1Δ/cup1Δ) transformed with plasmid KY969 carrying the CRP1-GFP fusion were visualized with Nomarski optics (Left) or by epifluorescence (Right).

Copper Toxicity Under Acidic Anaerobic Conditions.

C. albicans is found normally in the digestive tract of warm-blooded animals. This environment is largely anaerobic and in some parts very acidic. We tested whether the high copper resistance of C. albicans is related to these conditions. We found that when the pH of the yeast growth medium, normally 4.5–5.5, is reduced to 3, cells become significantly more sensitive to copper (results not shown). When cells are grown in anaerobic conditions and copper is added in the cuprous form [Cu(I)], the toxicity of copper is increased even more dramatically: even wild-type cells fail to grow in concentrations above 25 μM (Fig. 9). Under these conditions, the Cacrp1Δ mutant fails to grow even in 2 μM Cu+, i.e., at physiological concentrations of copper in the digestive tract (47).

Figure 9.

Figure 9

Growth inhibition by Cu+ in acidic anaerobic conditions. Cultures of the indicated strains were inoculated into 15-ml screw-capped tubes filled to the rim with synthetic complete medium pH 3, supplemented with ergosterol (10 μg/ml), oleic acid (0.5 mg/ml), and CuCl at the indicated concentrations and incubated at 30°C without shaking for 3 days.

Discussion

C. albicans is estimated to be about 108 years removed in evolution from S. cerevisiae. During that time, both yeasts have diverged as a result of adaptation to very different environments—the animal body and rotting fruit. The question at the basis of our study is whether comparison between the two organisms can yield insights into the requirements of life in the animal body. The animal host presents numerous challenges for microorganisms attempting to invade and colonize it. An important component of host defenses consists in toxic challenges to the invading microorganism—e.g., the oxidative burst in engulfing macrophages. Can a differential resistance to toxic compounds between the two yeasts be explained by an adaptation to the interaction with the animal body?

We found that copper is a compound to which C. albicans displays increased resistance. We performed a functional complementation screen in S. cerevisiae for C. albicans genes involved in copper resistance. Two genes were found in our screen, a copper metallothionein and a copper extrusion pump. The derived protein sequence of CaCup1 is identical to the recently reported protein sequence of the main C. albicans copper-binding protein (48). The phenotype of a strain deleted of both genes indicates that they represent the two main mediators of copper resistance in C. albicans. Of these two genes, CaCRP1 plays the more prominent role in copper detoxification and is responsible for the high resistance of C. albicans to copper, compared with S. cerevisiae. The fact that CaCrp1 is more effective than CaCup1 at detoxification is not surprising, because an extrusion pump functions catalytically, whereas a chelating agent such as metallothionein functions stoichiometrically. Nonetheless, the phenotype of the Cacup1Δ mutant—notably that the basal level of CaCRP1 is markedly increased in the Cacup1Δ strain—indicates that CaCUP1 plays a role even in the presence of CaCRP1. By analogy with the regulation of copper metallothionein in S. cerevisiae and C. glabrata and on the basis of the sequence analysis of their promoters (Z.W. and D.K., unpublished data), we assume that CaCUP1 and CaCRP1 are under the regulation of a copper-responsive transcription factor. Thus, a higher basal level would reflect an elevated cytoplasmic copper concentration. Taken together, our data suggest that CaCrp1 functions in bulk efflux of copper, whereas CaCup1 scavenges residual copper in the cytoplasm.

Copper-transporting P-type ATPases in eukaryotes are implicated in copper transport to intracellular organelles. Both S. cerevisiae Ccc2 and the human Menkes and Wilson disease proteins were shown to be located in a trans-Golgi compartment, where they deliver copper required for the biogenesis of the ferroxidase Fet3 and of ceruloplasmin, respectively (2326). Ccc2 does not appear to play a role in copper detoxification. The Menkes and Wilson disease transporters, however, were shown to be able to migrate under certain circumstances to either the plasma membrane or to a vesicular compartment near the plasma membrane, presumably to extrude excess copper (25, 2729). Thus, it was possible that similarly CaCrp1 can differentially localize according to the copper concentration and carry out both functions. However, we found that, (i) CaCrp1-GFP displays plasma membrane localization (Fig. 8) rather than the punctate cytoplasmic localization characteristic of Ccc2 (46); (ii) CaCrp1 is unable to complement the iron requirement of a S. cerevisiae ccc2Δ mutant (data not shown); and (iii) a C. albicans crp1Δ/crp1Δ mutant is unaffected for growth on low iron (data not shown). In addition, a sequence search against the almost completed C. albicans genomic sequence database (http://www-sequence.stanford.edu/group/candida) revealed that the C. albicans genome contains a second putative copper-transporting P-type ATPase with higher homology to Ccc2 (39% identity, vs. 29% for CaCrp1; results not shown). Thus, it is possible that this second protein is the functional homolog of ScCcc2 for intracellular iron transport, whereas CaCrp1's only function is in copper detoxification.

Why does C. albicans, alone so far among eukaryotes, require a dedicated copper extrusion pump? This type of copper detoxification mechanism is found also in a number of prokaryotes. Strikingly, many of the bacteria having known copper extrusion pumps are commensal or pathogenic enteric organisms (911). In the animal body, copper concentration is indeed the highest in the digestive tract, particularly in the stomach and duodenum, but even there it probably does not exceed 10 μM (47). However, we found that under acidic anaerobic conditions, which prevail in that part of the digestive tract, copper becomes much more toxic. The MIC of copper in the Caccc2Δ mutant under these conditions is 2 μM, suggesting that the existence of a copper-extruding ATPase in C. albicans may have resulted from adaptation to its specific ecological niche, the animal gut.

Why is copper more toxic under anaerobic conditions? In S. cerevisiae, exposure to high copper leads to a shutdown of copper import (4, 1215) and to the increased synthesis of Cup1, which chelates the copper that did enter the cell (16). Because Cup1 acts stoichiometrically, the shutdown of copper import is crucial, because the cell would be unable to cope with continuing copper entry. Mechanisms to inhibit copper import include down-regulation of the CTR1 gene, which encodes the main copper transporter, as well as destabilization of the Ctr1 protein. We suggest that down-regulation of copper reduction is another important mechanism of shutdown of copper import. Because the substrate of the copper transporter is reduced copper, Cu(I), whereas normally copper is in its oxidized Cu(II) state, cupric reductases on the surface of the cell are an essential component of the copper import pathway (3, 4). Cells exposed to high extracellular copper could rapidly shut down copper import by inhibiting the activity of the cupric reductases, except if the extracellular copper is in the reduced Cu(I) form already. Cu(I) is rapidly oxidized under aerobic conditions but stable under anaerobic conditions. Furthermore, Cu(I) is extremely insoluble at neutral pH but becomes soluble at acidic pH. Thus, it is likely that Cu(I) is prevalent in the stomach. Under these conditions, shutdown of copper import may not be complete, hence the need for a catalytic mechanism of copper detoxification such as a copper extrusion pump.

Acknowledgments

We thank Dennis Thiele (University of Michigan, Ann Arbor), Haoping Liu (University of California at Irvine), Martin Goldway (Migal–Galilee Technological Center), Bob Stearman (National Cancer Institute, National Institutes of Health), Jonathan Gitlin (Washington University, St. Louis), Gerry Fink (Whitehead Institute), and Brendan Cormack and Valerie Culotta (Johns Hopkins University), for providing strains and plasmids, Galila Harel (Chemistry Laboratory, Israeli Ministry of Health) for help with atomic absorption spectrophotometry, Racheli Ofir for help with digital photomicrography, and Sara Selig for critical reading of the manuscript. This research was supported by grants from the Israel Science Foundation and the Israeli Ministry of Health to D.K.

Abbreviations

MIC

minimal inhibitory concentration

GFP

green fluorescent protein

Footnotes

This paper was submitted directly (Track II) to the PNAS office.

Data deposition: The sequences reported in this paper have been deposited in the GenBank database (accession nos. AF193508 and AF193509).

References

  • 1.Dancis A, Yuan D S, Haile D, Askwith C, Elde D, Moehle C, Kaplan J, Klausner R D. Cell. 1994;76:393–402. doi: 10.1016/0092-8674(94)90345-x. [DOI] [PubMed] [Google Scholar]
  • 2.Knight S A, Labbe S, Kwon L F, Kosman D J, Thiele D J. Genes Dev. 1996;10:1917–1929. doi: 10.1101/gad.10.15.1917. [DOI] [PubMed] [Google Scholar]
  • 3.Hassett R, Kosman D J. J Biol Chem. 1995;270:128–134. doi: 10.1074/jbc.270.1.128. [DOI] [PubMed] [Google Scholar]
  • 4.Georgatsou E, Mavrogiannis L A, Fragiadakis G S, Alexandraki D. J Biol Chem. 1997;272:13786–13792. doi: 10.1074/jbc.272.21.13786. [DOI] [PubMed] [Google Scholar]
  • 5.Halliwell B, Gutteridge J M C. In: Methods in Enzymology. Packer L, Glazer A N, editors. Vol. 186. San Diego: Academic; 1990. pp. 1–85. [DOI] [PubMed] [Google Scholar]
  • 6.Evans S L, Tolbert C, Arceneaux J E, Byers B R. Antimicrob Agents Chemother. 1986;29:342–343. doi: 10.1128/aac.29.2.342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Dunning J C, Ma Y, Marquis R E. Appl Environ Microbiol. 1998;64:27–33. doi: 10.1128/aem.64.1.27-33.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Strain J, Culotta V C. Mol Gen Genet. 1996;251:139–145. doi: 10.1007/BF02172911. [DOI] [PubMed] [Google Scholar]
  • 9.Odermatt A, Suter H, Krapf R, Solioz M. Ann NY Acad Sci. 1992;671:484–486. doi: 10.1111/j.1749-6632.1992.tb43836.x. [DOI] [PubMed] [Google Scholar]
  • 10.Ge Z, Taylor D E. FEMS Microbiol Lett. 1996;145:181–188. doi: 10.1111/j.1574-6968.1996.tb08575.x. [DOI] [PubMed] [Google Scholar]
  • 11.Bayle D, Wangler S, Weitzenegger T, Steinhilber W, Volz J, Przybylski M, Schafer K P, Sachs G, Melchers K. J Bacteriol. 1998;180:317–329. doi: 10.1128/jb.180.2.317-329.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Labbe S, Zhu Z, Thiele D J. J Biol Chem. 1997;272:15951–15958. doi: 10.1074/jbc.272.25.15951. [DOI] [PubMed] [Google Scholar]
  • 13.Yamaguchi-Iwai Y, Serpe M, Haile D, Yang W, Kosman D J, Klausner R D, Dancis A. J Biol Chem. 1997;272:17711–17718. doi: 10.1074/jbc.272.28.17711. [DOI] [PubMed] [Google Scholar]
  • 14.Ooi C E, Rabinovich E, Dancis A, Bonifacino J S, Klausner R D. EMBO J. 1996;15:3515–3523. [PMC free article] [PubMed] [Google Scholar]
  • 15.Jungmann J, Reins H A, Lee J, Romeo A, Hassett R, Kosman D, Jentsch S. EMBO J. 1993;12:5051–5056. doi: 10.1002/j.1460-2075.1993.tb06198.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Liu X D, Thiele D J. Methods. 1997;11:289–299. doi: 10.1006/meth.1996.0423. [DOI] [PubMed] [Google Scholar]
  • 17.Hamer D H, Thiele D J, Lemontt J E. Science. 1985;228:685–690. doi: 10.1126/science.3887570. [DOI] [PubMed] [Google Scholar]
  • 18.Fu D, Beeler T J, Dunn T M. Yeast. 1995;11:283–292. doi: 10.1002/yea.320110310. [DOI] [PubMed] [Google Scholar]
  • 19.Chelly J, Tumer Z, Tonnesen T, Petterson A, Ishikawa-Brush Y, Tommerup N, Horn N, Monaco A P. Nat Genet. 1993;3:14–19. doi: 10.1038/ng0193-14. [DOI] [PubMed] [Google Scholar]
  • 20.Mercer J F, Livingston J, Hall B, Paynter J A, Begy C, Chandrasekharappa S, Lockhart P, Grimes A, Bhave M, Siemieniak D, et al. Nat Genet. 1993;3:20–25. doi: 10.1038/ng0193-20. [DOI] [PubMed] [Google Scholar]
  • 21.Vulpe C, Levinson B, Whitney S, Packman S, Gitschier J. Nat Genet. 1993;3:7–13. doi: 10.1038/ng0193-7. [DOI] [PubMed] [Google Scholar]
  • 22.Bull P C, Thomas G R, Rommens J M, Forbes J R, Cox D W. Nat Genet. 1993;5:327–337. doi: 10.1038/ng1293-327. [DOI] [PubMed] [Google Scholar]
  • 23.Yuan D S, Stearman R, Dancis A, Dunn T, Beeler T, Klausner R D. Proc Natl Acad Sci USA. 1995;92:2632–2636. doi: 10.1073/pnas.92.7.2632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Yamaguchi Y, Heiny M E, Suzuki M, Gitlin J D. Proc Natl Acad Sci USA. 1996;93:14030–14035. doi: 10.1073/pnas.93.24.14030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Hung I H, Suzuki M, Yamaguchi Y, Yuan D S, Klausner R D, Gitlin J D. J Biol Chem. 1997;272:21461–21466. doi: 10.1074/jbc.272.34.21461. [DOI] [PubMed] [Google Scholar]
  • 26.Payne A S, Gitlin J D. J Biol Chem. 1998;273:3765–3770. doi: 10.1074/jbc.273.6.3765. [DOI] [PubMed] [Google Scholar]
  • 27.Petris M J, Mercer J F, Culvenor J G, Lockhart P, Gleeson P A, Camakaris J. EMBO J. 1996;15:6084–6095. [PMC free article] [PubMed] [Google Scholar]
  • 28.Strausak D, La Fontaine S, Hill J, Firth S D, Lockhart P J, Mercer J F. J Biol Chem. 1999;274:11170–11177. doi: 10.1074/jbc.274.16.11170. [DOI] [PubMed] [Google Scholar]
  • 29.Goodyer I D, Jones E E, Monaco A P, Francis M J. Hum Mol Genet. 1999;8:1473–1478. doi: 10.1093/hmg/8.8.1473. [DOI] [PubMed] [Google Scholar]
  • 30.Richardson M D, Warnock D W. Fungal Infection: Diagnosis and Management. Oxford: Blackwell; 1997. [Google Scholar]
  • 31.Liu H, Kohler J, Fink G R. Science. 1994;266:1723–1726. doi: 10.1126/science.7992058. [DOI] [PubMed] [Google Scholar]
  • 32.Sikorski R S, Hieter P. Genetics. 1989;122:19–27. doi: 10.1093/genetics/122.1.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Fonzi W A, Irwin M Y. Genetics. 1993;134:717–728. doi: 10.1093/genetics/134.3.717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Cormack B P, Bertram G, Egerton M, Gow N A, Falkow S, Brown A J. Microbiology. 1997;143:303–311. doi: 10.1099/00221287-143-2-303. [DOI] [PubMed] [Google Scholar]
  • 35.Sherman F, Fink G R, Hicks J B. Methods in Yeast Genetics. Plainview, NY: Cold Spring Harbor Lab. Press; 1986. [Google Scholar]
  • 36.Liu X D, Thiele D J. Genes Dev. 1996;10:592–603. doi: 10.1101/gad.10.5.592. [DOI] [PubMed] [Google Scholar]
  • 37.Boeke J D, LaCroute F, Fink G R. Mol Gen Genet. 1984;197:345–346. doi: 10.1007/BF00330984. [DOI] [PubMed] [Google Scholar]
  • 38.DiDonato M, Narindrasorasak S, Forbes J R, Cox D W, Sarkar B. J Biol Chem. 1997;272:33279–33282. doi: 10.1074/jbc.272.52.33279. [DOI] [PubMed] [Google Scholar]
  • 39.Lutsenko S, Petrukhin K, Cooper M J, Gilliam C T, Kaplan J H. J Biol Chem. 1997;272:18939–18944. doi: 10.1074/jbc.272.30.18939. [DOI] [PubMed] [Google Scholar]
  • 40.Gitschier J, Moffat B, Reilly D, Wood W I, Fairbrother W J. Nat Struct Biol. 1998;5:47–54. doi: 10.1038/nsb0198-47. [DOI] [PubMed] [Google Scholar]
  • 41.Kyte J, Doolittle R F. J Mol Biol. 1982;157:105–132. doi: 10.1016/0022-2836(82)90515-0. [DOI] [PubMed] [Google Scholar]
  • 42.Peña M M O, Koch K A, Thiele D J. Mol Cell Biol. 1998;18:2514–2523. doi: 10.1128/mcb.18.5.2514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Thiele D J. Mol Cell Biol. 1988;8:2745–2752. doi: 10.1128/mcb.8.7.2745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Zhou P B, Thiele D J. Proc Natl Acad Sci USA. 1991;88:6112–6116. doi: 10.1073/pnas.88.14.6112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Thorvaldsen J L, Sewell A K, McCowen C L, Winge D R. J Biol Chem. 1993;268:12512–12518. [PubMed] [Google Scholar]
  • 46.Yuan D S, Dancis A, Klausner R D. J Biol Chem. 1997;272:25787–25793. doi: 10.1074/jbc.272.41.25787. [DOI] [PubMed] [Google Scholar]
  • 47.Underwood E J. Trace Elements in Human and Animal Nutrition. London: Academic; 1977. [Google Scholar]
  • 48.Oh K B, Watanabe T, Matsuoka H. Microbiology. 1999;145:2423–2429. doi: 10.1099/00221287-145-9-2423. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES